MAPP Releases Drugs in the Workplace Report


April 20, 2018

MAPP Releases Drugs in the Workplace Report

Indianapolis, IN – The Manufacturers Association for Plastics Processors (MAPP) recently conducted a drugs in the workplace survey.  The study resulted in a benchmarking report that analyzes workplace drug policies and procedures from manufacturing facilities across the U.S.

The 2018 Drugs in the Workplace Report is a 193-page document that includes analysis of inputs from over 110 US manufacturers in regard to their organization's drug policies. Topics highlighted include legality of marijuana, type of testing conducted, drugs screened during testing, accident documentation, company EAPs and adaptations due to the current opioid crisis.

Along with an analysis of findings, the report includes 48 unique drug policies submitted by manufacturers. These policies have been scrubbed of company-identifying information and serve as a benchmark and inspiration for those organizations looking to update, improve or implement a drug policy in their establishment.

“With the differing laws on legal marijuana, as well as the concern about opioids in the U.S. today, this report could not be timelier. Our hope is that it may provide some guidance to our members and the industry looking to improve their own policies and access what other manufacturers are doing nationwide,” says Troy Nix, MAPP executive director.

For more information or to purchase this report, visit  

#  #  #

Established in 1996, the Manufacturers Association for Plastic Processors is managed by plastics business leaders and has over 400 member companies nationwide. The association works to provide manufacturers with bottom line impacting programs, networking, and additional beneficial services.